<DOC>
	<DOCNO>NCT02029209</DOCNO>
	<brief_summary>1 . To reveal change peripheral marker blood perfusion parameter vivo tumor phase II study anlotinib patient advance non-small cell lung cancer . 2 . To clarify mean peripheral marker blood perfusion parameter vivo tumor predict effect anti-angiogenic therapy .</brief_summary>
	<brief_title>To Predict Efficacy Detecting Circulating Endothelial Cell Subsets Blood Perfusion Parameters Changes Vivo Tumor Phase II/III Study Anlotinib Patients With Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . Pathology diagnose advanced NSCLC measurable lesion ; 2 . Have fail 2 line chemotherapy ; 3.1870 year , ECOG PS:02 , life expectancy 3 month ; 4.Other cytotoxic drug , radiation therapy , surgery≥4 week ; 5.Main organ function normal ; 6.Women childbearing age take contraceptive measure study within 6 month end . 1 . SCLC ( include mixed NSCLC ) ; 2 . The central cavity Squamous cell carcinoma hemoptysis NSCLC ; 3 . Patients fail use antitumor angiogenesis therapy ; 4 . Patients many influence factor toward oral medication ; 5 . Brain metastasis patient accompany symptoms symptom control less two month ; 6 . Patients severe fail controlled disease , include : suboptimal blood pressure control ; suffer myocardial ischemia grade I myocardial infarction , arrhythmias Class I heart failure ; activity failure control severe infection ; liver disease cirrhosis , decompensated liver disease , chronic active hepatitis ; poorly control diabetes ( FBG &gt; 10mmol/L ) ; urine protein≥++ , etc . 7 . Patients fail heal wound fracture Longterm ; 8 . 4 week enrollment , patient appear NCI CTC AE grade &gt; 1 pulmonary hemorrhage ; 4 week enrollment , patient appear NCI CTC AE grade &gt; 2 part bleed ; patient tendency bleed ( e.g active peptic ulcer ) receive thrombolytic anticoagulant therapy Warfarin , heparin analogue ; 9 . Patients occur venous thromboembolic event within 6 month ; 10 . Patients HIVpositive organ transplantation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>